rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Hariharan Shankar

Co-CEO & Chairman

Company insider

Files Form 4 as: Co-CEO & Chairman, Scienture Holdings.

In numbers

Trades disclosed
16
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
19 Sep 2024
Last trade
20 Feb 2026
Last filed
12 Mar 2026

Companies traded

Where they are an officer
SCNX Scienture HoldingsDirector, Officer, 10% owner · Pharmaceuticals · last 20 Feb 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
20 Feb 2026filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code A—500,000 at $0.00filing
20 Feb 2026filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code A—500,000 at $0.00filing
1 Oct 2025filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code A—300,000 at $0.00filing
1 Oct 2025filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code A—300,000 at $0.00filing
14 Apr 2025filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code A—750,000 at $0.00filing
14 Apr 2025filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code A—750,000 at $0.00filing
10 Mar 2025filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code J—30,000 at $0.00filing
10 Mar 2025filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code J—30,000 at $0.00filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code C—1,916,816filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code C—356,480filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code C—1,916,816 at $0.00filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code C—356,480 at $0.00filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code C—1,916,816 at $0.00filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture Holdingsoption or derivative · PharmaceuticalsSEC FORM 4 Code C—356,480 at $0.00filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code C—1,916,816filing
19 Sep 2024filed 12 Mar 2026SCNX Scienture HoldingsPharmaceuticalsSEC FORM 4 Code C—356,480filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Mani NarasimhanPresident & Co-CEO · President & Co-CEO at Scienture Holdings, filing Form 4 there in the last year